Skip to main content

Home/ Cancer/ Group items tagged head_and_neck_cancer survival medline benefits

Rss Feed Group items tagged

Matti Narkia

Factors Associated With Clinical Benefit From Epidermal Growth Factor Receptor Inhibito... - 0 views

    Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
    Cohen EE, Halpern AB, Kasza K, Kocherginsky M, Williams R, Vokes EE.
    Oral Oncol. 2009 Oct;45(10):e155-60. Epub 2009 Jul 7.
    PMID: 19586795
1 - 1 of 1
Showing 20 items per page